This announcement is a separate document:
*ST龙津：中审众环会计师事务所（特殊普通合伙）关于昆明龙津药业股份有限公司2023年年报问询函的回复
Kunming Longjin Pharmaceutical: Response from China Audit Zhonghuan Certified Public Accountants (Special General Partnership) to the inquiry letter on the 2023 annual report of Kunming Longjin Pharmaceutical Co., Ltd.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.